168P Development of a combined clinical model to predict progression-free survival (PFS) in advanced breast cancer (ABC) treated with CDK4/6 inhibitors (CDK4/6i).

Authors :: Martínez-Sáez, O.
Menichetti, A.
Pare Brunet, L.
Griguolo, G.
Rodriguez Hernandez, A.
Pascual, T.
Dieci, M.V.
Conte, P.F.
Giorgi, C.A.
Brasó-Maristany, F.
Chic, N.
Martínez, D.
Rodríguez, A.
Schettini, F.
Conte, B.
Vidal, M.
Adamo, B.
Muñoz, M.
Prat, A.
Guarneri, V.
Source :: Annals of Oncology. 2020 Supplement 2, Vol. 31, pS76-S76. 1p.
Publication Year :: 2020

Subjects :: *BREAST cancer treatment
*CYCLIN-dependent kinase inhibitors
*CANCER hormone therapy
*PROGRESSION-free survival
*METASTASIS

Full Text Access

Tools